https://stock.noler.com/us/stock/nephrogenex-inc https://stock.noler.com/us/stock/nephrogenex-inc/accounts-payable https://stock.noler.com/us/stock/nephrogenex-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/nephrogenex-inc/accumulated-depreciation https://stock.noler.com/us/stock/nephrogenex-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/nephrogenex-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/nephrogenex-inc/additional-paid-in-capital https://stock.noler.com/us/stock/nephrogenex-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/nephrogenex-inc/aoci https://stock.noler.com/us/stock/nephrogenex-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/nephrogenex-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/nephrogenex-inc/capital-expenditures https://stock.noler.com/us/stock/nephrogenex-inc/cash-and-equivalents https://stock.noler.com/us/stock/nephrogenex-inc/cash-flow-breakdown https://stock.noler.com/us/stock/nephrogenex-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/nephrogenex-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/nephrogenex-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/nephrogenex-inc/clinical-trials https://stock.noler.com/us/stock/nephrogenex-inc/commitments-and-contingencies https://stock.noler.com/us/stock/nephrogenex-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/nephrogenex-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nephrogenex-inc/common-stock-value https://stock.noler.com/us/stock/nephrogenex-inc/comprehensive-income https://stock.noler.com/us/stock/nephrogenex-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/nephrogenex-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/nephrogenex-inc/current-assets https://stock.noler.com/us/stock/nephrogenex-inc/current-liabilities https://stock.noler.com/us/stock/nephrogenex-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/nephrogenex-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/nephrogenex-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/nephrogenex-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/nephrogenex-inc/debt-repaid https://stock.noler.com/us/stock/nephrogenex-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/nephrogenex-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/nephrogenex-inc/deferred-offering-costs https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-bonuses https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/nephrogenex-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nephrogenex-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/nephrogenex-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/nephrogenex-inc/depreciation https://stock.noler.com/us/stock/nephrogenex-inc/depreciation-and-amortization https://stock.noler.com/us/stock/nephrogenex-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nephrogenex-inc/effective-tax-rate https://stock.noler.com/us/stock/nephrogenex-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/nephrogenex-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/nephrogenex-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/nephrogenex-inc/form-d-other https://stock.noler.com/us/stock/nephrogenex-inc/form-d-stocks https://stock.noler.com/us/stock/nephrogenex-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/nephrogenex-inc/general-and-administrative-expense https://stock.noler.com/us/stock/nephrogenex-inc/income-tax https://stock.noler.com/us/stock/nephrogenex-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/nephrogenex-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/nephrogenex-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/nephrogenex-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/nephrogenex-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/nephrogenex-inc/insider-transactions-preferred https://stock.noler.com/us/stock/nephrogenex-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/nephrogenex-inc/interest-expense https://stock.noler.com/us/stock/nephrogenex-inc/interest-paid https://stock.noler.com/us/stock/nephrogenex-inc/interest-payable-current https://stock.noler.com/us/stock/nephrogenex-inc/investment-income-interest https://stock.noler.com/us/stock/nephrogenex-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/nephrogenex-inc/long-term-notes-payable https://stock.noler.com/us/stock/nephrogenex-inc/net-cash-from https://stock.noler.com/us/stock/nephrogenex-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/nephrogenex-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/nephrogenex-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/nephrogenex-inc/net-income https://stock.noler.com/us/stock/nephrogenex-inc/number-of-operating-segments https://stock.noler.com/us/stock/nephrogenex-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/nephrogenex-inc/oci-net-of-tax https://stock.noler.com/us/stock/nephrogenex-inc/operating-expenses https://stock.noler.com/us/stock/nephrogenex-inc/operating-income https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/nephrogenex-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/nephrogenex-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/nephrogenex-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/nephrogenex-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/nephrogenex-inc/other-noncurrent-assets https://stock.noler.com/us/stock/nephrogenex-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/nephrogenex-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/nephrogenex-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/nephrogenex-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/nephrogenex-inc/paid-in-kind-interest https://stock.noler.com/us/stock/nephrogenex-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/nephrogenex-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/nephrogenex-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/nephrogenex-inc/preferred-shares-facts https://stock.noler.com/us/stock/nephrogenex-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nephrogenex-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nephrogenex-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/nephrogenex-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/nephrogenex-inc/preferred-stock-value https://stock.noler.com/us/stock/nephrogenex-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/nephrogenex-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/nephrogenex-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/nephrogenex-inc/property-plant-equipment https://stock.noler.com/us/stock/nephrogenex-inc/public-float https://stock.noler.com/us/stock/nephrogenex-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/nephrogenex-inc/research-and-development https://stock.noler.com/us/stock/nephrogenex-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/nephrogenex-inc/retained-earnings https://stock.noler.com/us/stock/nephrogenex-inc/revenue-from-grants https://stock.noler.com/us/stock/nephrogenex-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/nephrogenex-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-10-k https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-10-q https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-25-nse https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-8-k https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-ars https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-certnas https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-def-14a https://stock.noler.com/us/stock/nephrogenex-inc/sec-filings-regdex https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/nephrogenex-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/nephrogenex-inc/secured-debt-current https://stock.noler.com/us/stock/nephrogenex-inc/secured-long-term-debt https://stock.noler.com/us/stock/nephrogenex-inc/share-price https://stock.noler.com/us/stock/nephrogenex-inc/shareholders-equity https://stock.noler.com/us/stock/nephrogenex-inc/shares-authorized https://stock.noler.com/us/stock/nephrogenex-inc/shares-issued https://stock.noler.com/us/stock/nephrogenex-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/nephrogenex-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/nephrogenex-inc/stock-based-compensation https://stock.noler.com/us/stock/nephrogenex-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/nephrogenex-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/nephrogenex-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/nephrogenex-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nephrogenex-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nephrogenex-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nephrogenex-inc/total-assets https://stock.noler.com/us/stock/nephrogenex-inc/total-liabilities https://stock.noler.com/us/stock/nephrogenex-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/nephrogenex-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/nephrogenex-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/nephrogenex-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/nephrogenex-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/nephrogenex-inc/weighted-average-number-of-share-outstanding-basic-and-diluted